Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. (TLSI) Stock Overview

Explore TriSalus Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TLSI●NASDAQ
HealthcareMedical - Devices
$5.27
$0.04(0.76%)
U.S. Market opens in 56h 24m

TriSalus Life Sciences, Inc. (TLSI)

Meyka AI Score

Z

Key Financials

Market Cap324.5M
P/E Ratio-4.08
EPS (TTM)$-1.68
ROE2.74%
Fundamental Analysis

AI Price Forecasts

1 Month$6.47
3 Months$3.18
1 Year Target$3.43

TLSI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of TriSalus Life Sciences, Inc. (NASDAQ: TLSI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, TriSalus Life Sciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TLSI on the NASDAQ shows an RSI of 58.23, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.43 for the NASDAQ listing.

Key metrics behind TriSalus Life Sciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -4.08 and a market capitalization of 324.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of TLSI on the NASDAQ.

Price Performance (NASDAQ: TLSI)

1-Day Change
0.76%
5-Day Change
-5.72%
1-Month Change
21.43%
3-Month Change
52.75%
6-Month Change
-3.30%
Year-to-Date (YTD) Change
-24.50%
1-Year Change
6.25%
3-Year Change
-41.25%
5-Year Change
-46.28%
All-Time (Max) Change
-49.90%

Contact Information

https://trisaluslifesci.com
888 321 5212
6272 West 91st Avenue, Westminster, CO, 80031

Company Facts

1,020 Employees
IPO DateFeb 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions